Learn More
Medchemexpress LLC 1-(4-(4-(2-((4-Chloro-3-(piperazin-1-ylsulfonyl)phenyl)amino)pyrimidin-4-yl)pyridin-2-yl)phenyl)-3-methyl... | 3056394-59-0 | 99.1% | 579.07 | 5 MG

Supplier: Medchemexpress LLC HY1611115MG
KVS0001 is a selective SMG1 inhibitor that elevates the expression of transcripts and proteins resulting from truncating mutations. It increases the presentation of immune-targetable HLA class I-associated peptides from nonsense-mediated decay (NMD)-downregulated proteins on the surface of cancer cells. KVS0001 exhibits anti-tumor properties and is suitable for research in NMD-related diseases, including cancer and inherited diseases.
- Selectively inhibits SMG1 protein over 246 other protein or lipid kinases.
- Elevates the expression of transcripts and proteins resulting from truncating mutations.
- Enhances the presentation of immune-targetable HLA class I-associated peptides from NMD-downregulated proteins on cancer cell surfaces.
- Exerts anti-tumor properties.
- Can be studied in research for NMD-related diseases, including cancer and inherited diseases.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.